← Back
Data updated: Mar 29, 2026
CHARTWELL
Infectious DiseaseDermatologyImmunology
Generics
CHARTWELL is a generic drug manufacturer focused on Infectious Disease, Dermatology, Immunology.
1973
Since
31
Drugs
-
Trials
601
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 38%
5 drugs
Dermatology 23%
3 drugs
Immunology 23%
3 drugs
Cardiovascular 8%
1 drugs
Respiratory 8%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Infectious Disease, Dermatology, Immunology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Immunology
Novartis big-pharma
Cardiovascular, Immunology, Respiratory
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Dermatology, Immunology
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Respiratory
Active (14)
Discontinued (17)
OXYCODONE AND ACETAMINOPHEN FLUCONAZOLE HYDROCODONE BITARTRATE AND ACETAMINOPHEN ACETAMINOPHEN AND CODEINE PHOSPHATE METFORMIN HYDROCHLORIDE SULFASALAZINE ALLOPURINOL AMOXICILLIN TERBINAFINE HYDROCHLORIDE MEMANTINE HYDROCHLORIDE DUTASTERIDE VIRILON FENOFIBRATE (MICRONIZED) CIPROFLOXACIN PHENDIMETRAZINE TARTRATE BENZPHETAMINE HYDROCHLORIDE METAPROTERENOL SULFATE
Company Info
- First Approval
- 1973-11-12
- Latest
- 2025-12-23
- Applications
- 38